These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
6. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Kesselheim AS; Fischer MA; Avorn J Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191 [TBL] [Abstract][Full Text] [Related]
7. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696 [TBL] [Abstract][Full Text] [Related]
8. Critical review and recommendations for nesiritide use in the emergency department. Collins SP; Hinckley WR; Storrow AB J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453 [TBL] [Abstract][Full Text] [Related]
9. The lost decade of nesiritide. Topol EJ N Engl J Med; 2011 Jul; 365(1):81-2. PubMed ID: 21732841 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]
11. Risk of death with nesiritide. Burger AJ JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377 [No Abstract] [Full Text] [Related]
12. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
13. Nesiritide vs nitroglycerin for decompensated congestive heart failure. Rifkin W JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662 [No Abstract] [Full Text] [Related]
15. Nesiritide: the wrong controversy. Somberg JC Am J Ther; 2005; 12(5):377-8. PubMed ID: 16148421 [No Abstract] [Full Text] [Related]
16. Nesiritide: the latest drug for treating heart failure. Fontana D Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809 [No Abstract] [Full Text] [Related]
17. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. Elkayam U; Akhter MW; Singh H; Khan S; Usman A Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359 [TBL] [Abstract][Full Text] [Related]
18. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Emerman CL Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure. Saltzberg MT Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915 [TBL] [Abstract][Full Text] [Related]
20. Re: Critical review and recommendations for nesiritide use in the Emergency Department. Levine M J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636 [No Abstract] [Full Text] [Related] [Next] [New Search]